ANTIBODIES THAT BIND TO SARS-COV-2

To provide novel antibodies that allow for prevention and/or treatment of COVID-19.SOLUTION: Disclosed is an antibody or fragment thereof that binds to S1 subunit of SARS-CoV-2, which comprises a heavy chain CDR1 of a specific amino acid sequence, a heavy chain CDR2 of a specific amino acid sequence...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHIGA HAZUKI, MATSUKURA SUSUMU, WATANABE SHINYA, HOSHI HIROTAKA, SATO SHIGEKO, IMAI JUNICHI
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	ACCESSORIES BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY OUTERWEAR PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS PROTECTIVE GARMENTS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS SPIRITS TESTING THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES VINEGAR WEARING APPAREL WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide novel antibodies that allow for prevention and/or treatment of COVID-19.SOLUTION: Disclosed is an antibody or fragment thereof that binds to S1 subunit of SARS-CoV-2, which comprises a heavy chain CDR1 of a specific amino acid sequence, a heavy chain CDR2 of a specific amino acid sequence, a heavy chain CDR3 of a specific amino acid sequence, a light chain CDR1 of a specific amino acid sequence, a light chain CDR2 of a specific amino acid sequence and a light chain CDR3 of a specific amino acid sequence.SELECTED DRAWING: None 【課題】本発明は、COVID-19に対する感染予防および／または治療を可能とする新規抗体の提供を課題とする。【解決手段】特定のアミノ酸配列からなる重鎖CDR１、特定のアミノ酸配列からなる重鎖CDR2、特定のアミノ酸配列からなる重鎖CDR3、特定のアミノ酸配列からなる軽鎖CDR1、特定のアミノ酸配列からなる軽鎖CDR2、および、特定のアミノ酸配列からなる軽鎖CDR3を有する抗体であって、SARS-CoV-2のS1サブユニットに結合する、抗体またはその抗体フラグメント。【選択図】なし